Study finds Philips ventilator helps reduce hospital readmissions for COPD
|Philips' Trilogy100--Courtesy of Philips|
Out of 397 COPD patients who were previously readmitted to the hospital two or more times within the past year, only 9 (2.2%) were readmitted on two or more occasions when put on a treatment protocol that included noninvasive positive-pressure ventilation delivered by Philips' Trilogy100 ventilator.
Philips points out that the Centers for Medicare & Medicaid Services added COPD to the list of conditions factored in the so-called Hospital Readmissions Reductions Program in fiscal year 2015, meaning 30-day readmissions for the group of lung diseases that make breathing difficult will be factored into CMS decisions about which hospitals to penalize for high readmission rates.
The company says 30-day readmissions for COPD are as high as 22.6% and that hospital stays for the disease cost the U.S. healthcare system about $29.5 billion.
"The results of this are more critical now more than ever, given the industry's increased focus on the high cost of chronic diseases and the need to reduce the re-hospitalization of COPD patients," said Eli Diacopoulos, vice president and general manager of Philips Respironics, in a statement. "The use of Trilogy in this COPD management program is just one example of our ability to work with an innovative homecare provider partner to achieve a new kind of COPD care management model that connects and supports the clinician, caregiver, home care provider and the patient at every point along the patient care path."
Other aspects of the study's treatment protocol included respiratory therapist-led care, medication reconciliation and adequate provision of oxygen therapy.
The Trilogy100 delivers volume and pressure ventilation invasively or noninvasively and can be used in patients' homes. Philips touts its light weight (11 pounds) and versatility, as well as the benefits of home healthcare. The device's screen displays the ventilation's settings and patient monitoring information, such as a log of events that caused the alarm to go off, according to the product website.
Philips sells off infant respiratory tech to sleep apnea upstart
Philips and Teva jump-start Israeli med tech incubator
Philips readies launch of smart device-based ultrasound device, app
FDA hits Philips Respironics with a Class I recall over ventilator power glitch